Anixa (ANIX) Director Lewis H. Titterton Jr. Buys 49,036 Shares

What Happened

• Lewis H. Titterton Jr., a director of Anixa Biosciences, reported an open-market purchase of 49,036 shares of ANIX on 2026-09-23.
• The shares were acquired at $2.69 per share for a total cost of approximately $131,907. This was a purchase (transaction code P), which is a direct acquisition of common stock.

Key Details

• Transaction date and price: 2026-09-23 — 49,036 shares at $2.69 each.
• Total value: approximately $131,907.
• Transaction type: Open-market purchase (code P).
• Shares owned after transaction: Not specified in the excerpt provided from the Form 4.
• Filing: Form 4 filed on 2026-09-25 (filed within two business days of the transaction; not marked late).
• No derivative activity, tax-withholding, 10b5-1 plan, or other special footnotes were indicated in the provided details.

Context

• Open-market purchases by directors are factual signals that the insider acquired equity; they do not, by themselves, prove intent or predict future performance. For retail investors, purchases can be more informative than routine sales because they increase the insider’s stake in the company. Always consider this trade alongside company fundamentals and broader market factors before drawing investment conclusions.